FDXR and Friedreich ataxia: Antioxidants (especially idebenone), iron chelators, mitochondrial-related agents, nuclear factor erythroid-derived 2-related factor 2 activators, and gene therapy are potential treatments for Friedreich ataxia [34] and candidates for novel therapies in FDXR-associated disorders.